| 000 | 01063 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516124015.0 | ||
| 264 | 0 | _c20130813 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1532-1967 | ||
| 024 | 7 |
_a10.1016/j.ctrv.2012.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOkroj, Marcin | |
| 245 | 0 | 0 |
_aEffector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies. _h[electronic resource] |
| 260 |
_bCancer treatment reviews _cOct 2013 |
||
| 300 |
_a632-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntigens, CD20 _xbiosynthesis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 700 | 1 | _aÖsterborg, Anders | |
| 700 | 1 | _aBlom, Anna M | |
| 773 | 0 |
_tCancer treatment reviews _gvol. 39 _gno. 6 _gp. 632-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ctrv.2012.10.008 _zAvailable from publisher's website |
| 999 |
_c22326676 _d22326676 |
||